Respiratory heaters are external heaters used with a nebulizer system. Nebulizer is a drug delivery device which allows inhalation of the drug directly into the lungs. Respiratory heaters provides the heated breathing gas and heated aerosol to the patients who required the respiratory support through nasal cannulae and tracheal tube. Respiratory heaters has the ability of mixing the oxygen and warm ambient air to users.

The high flow therapy is a type of respiratory support method which provides the high flow of medical gas through nasal cannulae. The respiratory heater warms the solution in the nebulizer and heats the diluted air. Respiratory heaters are used by patients who require the high flow therapy. These are used for treatment of asthma, chronic obstructive pulmonary disease, and bronchitis.

Ask for the Sample of the Study: https://www.coherentmarketinsights.com/insight/request-sample/2613

An increase in prevalence and incidence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) is a major factor that is expected to augment growth of respiratory heaters market. The Global Burden of Disease Study gives the prevalence of 251 million cases of COPD in 2016 and the bronchial asthma has approximately 358.2 million cases in 2015. The market is also driven by factors such as growing geriatric population, high prevalence of smoking, increasing pollution level. COPD is a progressive life threatening lung disease which is not curable but can be controlled by respiratory heaters. COPD is an under-diagnosed, life threatening lung disease that may progressively lead to death.

On the other hand, high cost of devices and undefined reimbursement policies in rural areas are factors restraining the market growth. For instance, on 12 December 2017, Teleflex Incorporated, a leading global provider of medical technologies, announced that its respiratory division has signed a new group purchasing agreement with Health Trust. The agreement covers Teleflex's full line of active humidification, non-invasive ventilation (NIV), and high flow nasal cannula therapy (HFNCT) products.

Click to view the full report TOC, figure and tables: https://www.coherentmarketinsights.com/ongoing-insight/toc/2613

On the basis of region, respiratory heaters market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America contributed the largest regional share in the global respiratory heater device market in 2018. Key factors driving the robust growth of North America region include well developed healthcare infrastructure, increasing prevalence of asthma and chronic obstructive pulmonary disease among children and geriatric population, presence of key regional players, and strong distribution network.

In 2017, GGM’s high flow oxygen system, HUMIDOFLO HF-2900, received an award at the Taiwan Excellence Awards. Humidoflo provides more patient friendly and effective treatment for both pediatric and adult patients. GGM’s HF2900D Humidoflo represents the new state of art technology for delivery of high standard high flow therapy for pediatric and adult patients. The high flow delivery of oxygen or humidity can increase the tracheal temperature and humidity. Compared to other conventional mask type oxygen therapies, HUMIDOFLO delivers high flows of blended oxygen through unique nasal cannula.

For More Information On This Report, Please Visit @ https://www.coherentmarketinsights.com/ongoing-insight/respiratory-heaters-market-2613

Key players operating in the market include Teleflex Ink. , Care Fusion Corporation, Armstrong Medical, Healthcare Trust and Mediline industries, Great Group Medical., Co., Ltd, and GE Healthcare